Abstract
Tetracosactide is a synthetic peptide analogue of the human adrenocorticotropic hormone that stimulates the production of cortisol in the adrenal cortex. The medical use of the compound is primarily the diagnosis of the adrenal cortex function. In order to characterize impurities of the drug, tetracosactide samples were analysed by both liquid chromatography and capillary electrophoresis coupled to a quadrupole time-of-flight mass spectrometer. The identification of the impurities was carried out based on accurate mass determination and fragment ion spectra. The presence of several peptides of lower and higher masses than tetracosactide could be shown, including N- and C-terminally truncated peptides as well as peptides which still contained protecting groups or additional amino acids. Furthermore, a semi-quantitative estimation of the relative amounts of the impurities in different samples as well as a commercial preparation revealed that the number and the type of the impurities varied between the samples. Comparing the selectivity of liquid chromatography and capillary electrophoresis regarding the separation of tetracosactide impurities, it can be stated that capillary electrophoresis showed a higher suitability for the separation of tetracosactide fragments (smaller peptides) while the larger peptides, i.e. those wearing protecting groups, were separated more efficiently by liquid chromatography.
Similar content being viewed by others
References
Schwyzer R, Kappeler H (1963) Synthese eines Tetracosapeptides mit hoher corticotroper Wirksamkeit: β1–24-Corticotropin. Helvetica Chimica Acta 46(5):1550–1572
Toft A, Irvine W (1974) Hormonal Effects of Synthetic ACTH Analogues. Proc R Soc Med 67:749–750
Vogeser M, Zachoval R, Jacob K (2001) Serum cortisol/cortisone ratio after Synacthen stimulation. Clin Biochem 34(5):421–425
Bridges NA, Hindmarsh PC, Pringle PJ, Honour JW, Brook CGD (1998) Cortisol, Androstenedione (A4), Dehydroepiandrosterone Sulphate (DHEAS) and 17 Hydroxyprogesterone (17OHP) Responses to Low Doses of (1–24)ACTH. J Clin Endocrinol Metab 83(10):3750–3753
Otto H, Minneker C, Spaethe R (1966) Synacthen-Kurztest zur Beurteilung der Nebennierenrindenfunktion (Intravenous injection of corticotropin β1—24 in the rapid diagnosis of adrenal cortical function). Dtsch Med Wochenschr 91(20):934–939
Crowley S, Hindmarsh PC, Holownia P, Honour JW, Brook CGD (1991) The use of low doses of ACTH in the investigation of adrenal function in man. J Endocrinol 130(3):475–479
Agwu JC, Spoudeas H, Hindmarsh PC, Pringle PJ, Brook CGD (1999) Tests of adrenal insufficiency. Arch Dis Child 80(4):330–333
Alía P, Villabona C, Giménez O, Sospedra E, Soler J, Navarro MA (2006) Profile, mean residence time of ACTH and cortisol responses after low and standard ACTH tests in healthy volunteers. Clin Endocrinol 65(3):346–351
Collomp K, Arlettaz A, Portier H, Lecoq A-M, Le Panse B, Rieth N, De Ceaurriz J (2008) Short-term glucocorticoid intake combined with intense training on performance and hormonal responses. Br J Sports Med 42(12):983–988
Soetens E, Hueting J, Meirleir K (1995) No influence of ACTH on maximal performance. Psychopharmacology 118(3):260–266
Baume N, Steel G, Edwards T, Thorstensen E, Miller B (2008) No variation of physical performance and perceived exertion after adrenal gland stimulation by synthetic ACTH (Synacthen®) in cyclists. Eur J Appl Physiol 104(4):589–600
WADA (2011) The 2011 Prohibited List. http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/To_be_effective/WADA_Prohibited_List_2011_EN.pdf. Accessed Jan 18 2011
Jeffcoate WJ, Phenekos C, Ratcliffe JG, Williams S, Rees L, Besser GM (1977) Comparison of the pharmacokinetics in man of two synthetic ACTH analogues: a1–24 and substituted β1–18 ACTH. Clin Endocrinol 7(1):1–11
Thevis M, Bredehöft M, Geyer H, Kamber M, Delahaut P, Schänzer W (2006) Determination of Synacthen in human plasma using immunoaffinity purification and liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 20(23):3551–3556
Thomas A, Kohler M, Schänzer W, Kamber M, Delahaut P, Thevis M (2009) Determination of Synacthen in urine for sports drug testing by means of nano-ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 23(17):2669–2674
Chaabo A, de Ceaurriz J, Buisson C, Tabet J-C, Lasne F (2011) Simultaneous quantification and qualification of synacthen in plasma. Anal Bioanal Chem 399(5):1835–1843
Tetracosactide (2011) In: European Pharmacopoeia. 7th edn. European Directorate of The Quality of Medicines, Strasbourg, p monograph 0644
(2011) https://extranet.edqu.eu/4DLink1/pdfs/chromatos/0644.pdf. Accessed April 20
Kasicka V (2010) Recent advances in CE and CEC of peptides (2007–2009). Electrophoresis 31(1):122–146
Kates SA, Albericio F (eds) (2000) Solid-Phase Synthesis: A Practical Guide. Marcel Dekker, Inc., New York
Chan WC, White PD (eds) (2000) Fmoc Solid Phase Peptide Synthesis - A Practical Approach. Oxford University Press, Oxford
Merrifield RB (1963) Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide. J Am Chem Soc 85(14):2149–2154
Cifuentes A, Poppe H (1997) Behavior of peptides in capillary electrophoresis: Effect of peptide charge, mass and structure. Electrophoresis 18(12–13):2362–2376
Adamson NJ, Reynolds EC (1997) Rules relating electrophoretic mobility, charge and molecular size of peptides and proteins. J Chromatogr B Biomed Sci Appl 699(1–2):133–147
Sanz-Nebot V, Benavente F, Toro I, Barbosa J (2003) Evaluation of chromatographic versus electrophoretic behaviour of a series of therapeutical peptide hormones. J Chromatogr A 985(1–2):411–423
Winzor DJ (2003) Classical approach to interpretation of the charge-dependence of peptide mobilities obtained by capillary zone electrophoresis. J Chromatogr A 1015(1–2):199–204
Tessier B, Blanchard F, Vanderesse R, Harscoat C, Marc I (2004) Applicability of predictive models to the peptide mobility analysis by capillary electrophoresis-electrospray mass spectrometry. J Chromatogr A 1024(1–2):255–266
Jalali-Heravi M, Shen Y, Hassanisadi M, Khaledi MG (2005) Prediction of electrophoretic mobilities of peptides in capillary zone electrophoresis by quantitative structure-mobility relationships using the offord model and artificial neural networks. Electrophoresis 26(10):1874–1885
Meek JL (1980) Prediction of peptide retention times in high-pressure liquid chromatography on the basis of amino acid composition. Proc Natl Acad Sci USA 77(3):1632–1636
Guo D, Mant CT, Taneja AK, Parker JMR, Rodges RS (1986) Prediction of peptide retention times in reversed-phase high-performance liquid chromatography I. Determination of retention coefficients of amino acid residues of model synthetic peptides. J Chromatogr A 359:499–518
Mant CT, Burke TWL, Black JA, Hodges RS (1988) Effect of peptide chain length on peptide retention behaviour in reversed-phase chromatogrphy. J Chromatogr A 458:193–205
Petritis K, Kangas LJ, Yan B, Monroe ME, Strittmatter EF, Qian W-J, Adkins JN, Moore RJ, Xu Y, Lipton MS, Camp DG, Smith RD (2006) Improved Peptide Elution Time Prediction for Reversed-Phase Liquid Chromatography-MS by Incorporating Peptide Sequence Information. Anal Chem 78(14):5026–5039
Spicer V, Grigoryan M, Gotfrid A, Standing KG, Krokhin OV (2010) Predicting Retention Time Shifts Associated with Variation of the Gradient Slope in Peptide RP-HPLC. Anal Chem 82(23):9678–9685
Tang XJ, Thibault P, Boyd RK (1993) Fragmentation reactions of multiply-protonated peptides and implications for sequencing by tandem mass spectrometry with low-energy collision-induced dissociation. Anal Chem 65(20):2824–2834
Roepstorff P, Fohlman J (1984) Letter to the editors: Proposal for a common nomenclature for sequence ions in mass spectra of peptides. Biol Mass Spectrom 11(11):601–601
Sanz-Nebot V, Toro I, Castillo A, Barbosa J (2001) Investigation of synthetic peptide hormones by liquid chromatography coupled to pneumatically assisted electrospray ionization mass spectrometry: analysis of a synthesis crude of peptide triptorelin. Rapid Commun Mass Spectrom 15(13):1031–1039
Sanz-Nebot V, Toro I, Garcés A, Barbosa J (1999) Separation and identification of peptide mixtures in a synthesis crude of carbetocin by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 13(23):2341–2347
Sanz-Nebot V, Benavente F, Barbosa J (2000) Separation and characterization of multicomponent peptide mixtures by liquid chromatography-electrospray ionization mass spectrometry: Application to crude products of the synthesis of leuprolide. J Chromatogr A 870(1–2):315–334
Sanz-Nebot V, Benavente F, Toro I, Barbosa J (2004) Separation and characterization of complex crude mixtures produced in the synthesis of therapeutic peptide hormones by liquid chromatography coupled to electrospray mass spectrometry (LC-ES-MS). Anal Chim Acta 521(1):25–36
Litowski JR, Semchuk PD, Mant CT, Hodges RS (1999) Hydrophilic interaction/cation-exchange chromatography for the purification of synthetic peptides from closely related impurities: serine side-chain acetylated peptides. J Pept Res 54(1):1–11
Bayer E (1991) Auf dem Weg zur chemischen Synthese von Proteinen. Angewandte Chemie 103(2):117–133
Acknowledgements
The Federal Institute for Drugs and Medical Devices (BfArM, Bonn, Germany) is gratefully acknowledged for providing the samples of TCS and its impurities. AT thanks the Thomas Gessmann Foundation for financial support.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary materials
Below is the link to the electronic supplementary material.
Table S1
(PDF 1.10 mb)
Rights and permissions
About this article
Cite this article
Taichrib, A., Scriba, G.K.E. & Neusüß, C. Identification and characterization of impurities of tetracosactide by capillary electrophoresis and liquid chromatography coupled to time-of-flight mass spectrometry. Anal Bioanal Chem 401, 1365–1375 (2011). https://doi.org/10.1007/s00216-011-5183-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-011-5183-0